Apply For Funding: Clinical Research Proposals

Proposal Guidelines


The Foundation's Board of Trustees has determined that funding will fall into the following categories: clinical research, physician and public awareness of the hazards of sleep-disordered breathing, and community philanthropic involvement. The primary focuses of Foundation Grants are "sleep and breathing," with limited funds available for community support.

Currently the Foundation plans to disburse a total of up to $1,350,000 annually. The Foundation will entertain proposals for multi-year studies, if warranted. However, for multi-year studies the Foundation will require an annual review at which time the board will ascertain whether the funded entity is keeping to its timeline and making progressive steps toward completion. The board may reserve the right to discontinue further funding if a study is not moving forward as outlined in the proposal, nor reaching recruitment goals.


Clinical Research Proposals

Application Deadline:
March 15
September 15
Decision Made By:
April 30
October 31


The ResMed Foundation's key mission is to promote novel research as well as public and clinician awareness of sleep disordered breathing (SDB) and other respiratory disorders, with a primary focus on positive airway pressure and ventilation-based treatments. The Foundation will consider proposals focused on the evaluation, diagnosis, treatment and management of SDB and other respiratory disorders. Research areas of interest include the most common and/or impactful comorbidities that are associated with SDB, especially metabolic syndrome including insulin sensitivity, obesity and especially cardiovascular diseases. Other areas of focus include SDB in conjunction with occupational health and safety, asthma, chronic obstructive pulmonary disease (COPD), and solid tumors. Specific focus is on outcomes that can influence clinical practice in the near term.

In 2022, the ResMed Foundation is particularly interested in:

  • Research proposals that utilize advanced analytics and data science, especially the use of Machine Learning (ML) and Artificial Intelligence (AI), in the analysis of large sets of data from a variety of relevant sources (EHR, lab, claims, sensors/wearables, connected devices, remote physiologic and remote therapeutic monitoring, software/digital health platforms, etc.).
  • Research based on real-world data (RWD) that generates high-quality real-world evidence (RWE).
  • Health Economics and Outcomes Research (HEOR).
  • Pragmatic research and clinical trials that accelerate the integration of research, policy and practice.

The Foundation encourages the publication of results in appropriate peer reviewed scientific and medical publications.

A few examples of programs that the Foundation has funded are highlighted under Grant Recipients.


Donor recipients must be a qualified tax-exempt organization under section 501 (c) 3 of the US Internal Revenue Service or have the equivalent designation by the federal governing agency in another country.

Grants will be given to organizations that demonstrate that they have competent management who have a history of delivering results in an effective and cost efficient manner.

Indirect costs: The Foundation's policy is to consider a maximum of 4% of indirect/overhead costs; however the board's preference is to fund direct (program) costs only.

Grants will be awarded with a clear expectation of measurable results and outcomes.

Reports to the Foundation will be required minimally on a semi-annual basis. In some cases quarterly reports are required. At the conclusion of the study a final report is required detailing how the funds were spent and definitive outcomes. The Foundation will be provided a copy of all abstracts and published reports.

A "Letter of Agreement" (LOA) between the grantee and grantor will be required once a grant has been approved, and prior to funding. Funding of Clinical Research grants are made in a minimum of two payments, with the first installment paid upon the grantor's receipt of two fully executed copies of the LOA. Subsequent payments will be contingent upon semi-annual reports and the Foundation board's assessment that patient recruitment is taking place and reasonable progress made.

In accordance with US Government policy, proof will be required that the organization is a legally designated not-for-profit organization and a legitimate research institution.